Literature DB >> 186222

Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.

M Jondal.   

Abstract

The capacity of antibodies, directed against EBV-determined membrane antigens (MA), to induce antibody-dependent cellular cytotoxicity (ADCC) against EBV superinfected lymphoid cell lines was investigated. Such reactive antibodies were found, at high dilutions, in sera from normal EBV-positive persons but not in sera from EBV-negative persons. Sera from patients with acute infectious mononucleosis (IM), which develop EBV-specific killer T cells, did not induce ADCC. The difference in specificity between ADCC and EBV-specific killer T cells is briefly discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 186222      PMCID： PMC1541383     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  14 in total

1.  Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Authors:  B Härfast; T Andersson; P Perlmann
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens.

Authors:  J Prevost; T W Orr; G R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

4.  T- and B-cell subpopulations in infectious mononucleosis.

Authors:  M Papamichail; P J Sheldon; E J Holborow
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

5.  Cellular immunity in subacute sclerosing panencephalitis.

Authors:  H Valdimarsson; G Agnarsdottir; P J Lachmann
Journal:  Proc R Soc Med       Date:  1974-11

Review 6.  The oncogenicity of Epstein-Barr virus.

Authors:  G Miller
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

7.  Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.

Authors:  A Adams
Journal:  J Gen Virol       Date:  1973-09       Impact factor: 3.891

8.  Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus.

Authors:  P Gunvén; G Klein
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

9.  Thymic origin of atypical lymphoid cells in infectious mononucleosis.

Authors:  P J Sheldon; E H Hemsted; M Papamichail; E J Holborow
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

10.  Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.

Authors:  W H Kreth; M Y Käckell; V ter Meulen
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422
View more
  17 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.

Authors:  A B Rickinson; D Crawford; M A Epstein
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

Review 3.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

4.  Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.

Authors:  P C Patel; J Menezes
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

5.  Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.

Authors:  R Scott; M O de Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

6.  Development of antibodies reactive in antibody-dependent cellular cytotoxicity in infectious mononucleosis.

Authors:  J F Hewetson; J F Böcker; P Sereni; C E Rapp; W Henle
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  The effects of prednisolone in leucocyte function in man. A double blind controlled study.

Authors:  J R Clarke; R F Gagnon; F M Gotch; M R Heyworth; I C Maclennan; S C Truelove; C A Waller
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

8.  p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.

Authors:  D Casareale; W Jones; T Sairenji; R E Humphreys
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

10.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.